Neuroscientific Biopharmaceuticals Ltd. has released a press release.
Remarkable Results from Patients treated with StemSmart
Earlier from Neuroscientific Biopharmaceuticals
- Half Yearly Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report
- Successful Clinical Results Achieved under Special Access
- Trading Halt